• 1334 Citations
  • 9 h-Index
20022018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 20 Similar Profiles
Indoleamine-Pyrrole 2,3,-Dioxygenase Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hemophagocytic Lymphohistiocytosis Medicine & Life Sciences
Antigen-Presenting Cells Medicine & Life Sciences
Neoplasm Antigens Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2018

Access to hematopoietic stem cell transplant for patients with sickle cell anemia

Meier, E. R., Johnson, T. S., Pinkney, K., Velez, M. C., Kamani, N. & Odame, I., Sep 1 2018, In : Pediatric Blood and Cancer. 65, 9, e27105.

Research output: Contribution to journalReview article

Hematopoietic Stem Cell Transplantation
Sickle Cell Anemia
Hematopoietic Stem Cells
Transplants
Siblings
5 Citations

Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+ Monocytic Antigen-Presenting Cells in Tumors

Sharma, M. D., Rodriguez, P. C., Koehn, B. H., Baban, B., Cui, Y., Guo, G., Shimoda, M., Pacholczyk, R. W., Shi, H., Lee, E. J., Xu, H., Johnson, T. S., He, Y., Mergoub, T., Venable, C., Bronte, V., Wolchok, J. D., Blazar, B. R. & Munn, D. H., Jan 16 2018, In : Immunity. 48, 1, p. 91-106.e6

Research output: Contribution to journalArticle

Antigen-Presenting Cells
Myeloid Cells
Immunotherapy
Cell Differentiation
Cross-Priming

Treg Destabilization and reprogramming: Implications for cancer immunotherapy

Munn, D. H., Sharma, M. D. & Johnson, T. S., Sep 15 2018, In : Cancer Research. 78, 18, p. 5191-5199 9 p.

Research output: Contribution to journalReview article

Immunotherapy
Neoplasms
PTEN Phosphohydrolase
Cross-Priming
Indoleamine-Pyrrole 2,3,-Dioxygenase
2 Citations

Chemo-immunotherapy: Role of indoleamine 2,3-dioxygenase in defining immunogenic versus tolerogenic cell death in the tumor microenvironment

Johnson, T. S., Mcgaha, T. & Munn, D. H., Jan 1 2017, Advances in Experimental Medicine and Biology. Springer New York LLC, Vol. 1036. p. 91-104 14 p. (Advances in Experimental Medicine and Biology; vol. 1036).

Research output: Chapter in Book/Report/Conference proceedingChapter

Indoleamine-Pyrrole 2,3,-Dioxygenase
Tumor Microenvironment
Cell death
Chemotherapy
Immunotherapy
8 Citations

IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment

Munn, D. H., Sharma, M. D., Johnson, T. S. & Rodriguez, P., May 9 2017, (Accepted/In press) In : Cancer Immunology, Immunotherapy. p. 1-10 10 p.

Research output: Contribution to journalArticle

Indoleamine-Pyrrole 2,3,-Dioxygenase
Tumor Microenvironment
Antigen Presentation
Immunosuppressive Agents
Cytotoxins